{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:28:50Z","timestamp":1787509730676,"version":"build-2736575974"},"reference-count":54,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,2,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Extramedullary disease (EMD) is known to be associated with chemoresistance and poor prognosis in multiple myeloma (MM); however, the mechanisms of its development are not fully understood. Elucidating the mechanism of EMD development and its therapeutic targeting would greatly contribute to further improvement of treatment outcome in patients with MM. Here, we show that bone marrow stroma cell\u2013derived hyaluronan (HA) elicits homophilic interactions of MM cells by binding to surface CD44, especially long-stretch variants, under physiological shear stress and generates cell clusters that might develop into EMD. We recapitulated the development of EMD via administration of HA in a syngeneic murine MM model in a CD44-dependent manner. HA-induced MM cell clusters exhibited the specific resistance to proteasome inhibitors (PIs) in\u00a0vitro and in murine models via \u03b3-secretase\u2013mediated cleavage of the intracellular domains of CD44, which in turn transactivated PI resistance-inducible genes. Treatment of HA-injected mice with anti-CD44 antibody or \u03b3-secretase inhibitors readily suppressed the development of EMD from transplanted MM cells and significantly prolonged the survival of recipients by overcoming PI resistance. The HA-CD44 axis represents a novel pathway to trigger EMD development and could be a target of the prediction, prevention, and treatment of EMD in patients with MM.<\/jats:p>","DOI":"10.1182\/bloodadvances.2022007291","type":"journal-article","created":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T14:57:04Z","timestamp":1659711424000},"page":"508-524","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":12,"title":["EMD originates from hyaluronan-induced homophilic interactions of CD44 variant-expressing MM cells under shear stress"],"prefix":"10.1182","volume":"7","author":[{"given":"Jiro","family":"Kikuchi","sequence":"first","affiliation":[{"name":"1Division of Stem Cell Regulation, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5279-029X","authenticated-orcid":false,"given":"Nobuyuki","family":"Kodama","sequence":"additional","affiliation":[{"name":"2Department of Hematology, Tokyo-Kita Medical Center, Tokyo, Japan"},{"name":"3International Myeloma Center for Advanced Research and Treatment, Japan Association for Development of Community Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2140-4007","authenticated-orcid":false,"given":"Masataka","family":"Takeshita","sequence":"additional","affiliation":[{"name":"2Department of Hematology, Tokyo-Kita Medical Center, Tokyo, Japan"},{"name":"3International Myeloma Center for Advanced Research and Treatment, Japan Association for Development of Community Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Ikeda","sequence":"additional","affiliation":[{"name":"4Department of Hematology, Nephrology and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9914-7517","authenticated-orcid":false,"given":"Takahiro","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"4Department of Hematology, Nephrology and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Kuroda","sequence":"additional","affiliation":[{"name":"5Department of Hematology, National Hospital Organization Hiroshimanishi Medical Center, Hiroshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihiro","family":"Uchiyama","sequence":"additional","affiliation":[{"name":"6Department of Hematology, Japanese Red Cross Society Suwa Hospital, Nagano, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Osada","sequence":"additional","affiliation":[{"name":"1Division of Stem Cell Regulation, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjarne","family":"Bogen","sequence":"additional","affiliation":[{"name":"7Institute of Immunology, Oslo University Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0905-6855","authenticated-orcid":false,"given":"Hiroshi","family":"Yasui","sequence":"additional","affiliation":[{"name":"8Department of Hematology\/Oncology, The Institute of Medical Science, University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6758-3787","authenticated-orcid":false,"given":"Naoto","family":"Takahashi","sequence":"additional","affiliation":[{"name":"4Department of Hematology, Nephrology and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyoshi","family":"Miwa","sequence":"additional","affiliation":[{"name":"2Department of Hematology, Tokyo-Kita Medical Center, Tokyo, Japan"},{"name":"3International Myeloma Center for Advanced Research and Treatment, Japan Association for Development of Community Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7249-6418","authenticated-orcid":false,"given":"Yusuke","family":"Furukawa","sequence":"additional","affiliation":[{"name":"1Division of Stem Cell Regulation, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,2,16]]},"reference":[{"issue":"1","key":"2023081515544601500_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"7835","key":"2023081515544601500_bib2","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1038\/d41586-020-03223-2","article-title":"Outlook: multiple myeloma","volume":"587","author":"Owens","year":"2020","journal-title":"Nature"},{"issue":"1","key":"2023081515544601500_bib3","doi-asserted-by":"crossref","first-page":"17046","DOI":"10.1038\/nrdp.2017.46","article-title":"Multiple myeloma","volume":"3","author":"Kumar","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"2023081515544601500_bib4","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s12185-020-02829-6","article-title":"Molecular basis of clonal evolution in multiple myeloma","volume":"111","author":"Furukawa","year":"2020","journal-title":"Int J Hematol"},{"issue":"1","key":"2023081515544601500_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajh.1067","article-title":"Clinical and pathologic findings in 52 consecutively autopsied cases with multiple myeloma","volume":"67","author":"Oshima","year":"2001","journal-title":"Am J Hematol"},{"issue":"10","key":"2023081515544601500_bib6","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/ajh.25579","article-title":"Hematogenous extramedullary relapse in multiple myeloma: a multicenter retrospective study in 127 patients","volume":"94","author":"Avivi","year":"2019","journal-title":"Am J Hematol"},{"issue":"9","key":"2023081515544601500_bib7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41408-021-00527-y","article-title":"Extramedullary disease in multiple myeloma","volume":"11","author":"Bansal","year":"2021","journal-title":"Blood Cancer J"},{"issue":"2","key":"2023081515544601500_bib8","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1080\/10428190802657751","article-title":"The impact of extramedullary disease at presentation on the outcome of myeloma","volume":"50","author":"Wu","year":"2009","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"2023081515544601500_bib9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/annonc\/mdp329","article-title":"Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients","volume":"21","author":"Varettoni","year":"2010","journal-title":"Ann Oncol"},{"issue":"2","key":"2023081515544601500_bib10","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3324\/haematol.2013.094409","article-title":"Soft-tissue extramedullary multiple myeloma prognosis is significantly worse in comparison to bone-related extramedullary relapse","volume":"99","author":"Pour","year":"2014","journal-title":"Haematologica"},{"issue":"1","key":"2023081515544601500_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41375-019-0660-0","article-title":"Extramedullary multiple myeloma","volume":"34","author":"Bhutani","year":"2020","journal-title":"Leukemia"},{"issue":"3","key":"2023081515544601500_bib12","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/bjh.17338","article-title":"Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations","volume":"194","author":"Rosi\u00f1ol","year":"2021","journal-title":"Br J Haematol"},{"issue":"6","key":"2023081515544601500_bib13","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/s41590-021-00947-9","article-title":"Inflammatory stromal cells in the myeloma microenvironment","volume":"22","author":"Sklavenitis-Pistofidis","year":"2021","journal-title":"Nat Immunol"},{"issue":"2","key":"2023081515544601500_bib14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/onc.2008.385","article-title":"Bortezomib overcomes cell-adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma","volume":"28","author":"Noborio-Hatano","year":"2009","journal-title":"Oncogene"},{"issue":"12","key":"2023081515544601500_bib15","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1172\/JCI80325","article-title":"Phosphorylation-mediated EZH2 inactivation promotes drug resistance in multiple myeloma","volume":"125","author":"Kikuchi","year":"2015","journal-title":"J\u00a0Clin Invest"},{"issue":"7","key":"2023081515544601500_bib16","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1158\/0008-5472.CAN-17-2446","article-title":"Myeloma cells are activated in bone marrow microenvironment by the CD180\/MD-1 complex which senses lipopolysaccharide","volume":"78","author":"Kikuchi","year":"2018","journal-title":"Cancer Res"},{"issue":"1","key":"2023081515544601500_bib17","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s41375-019-0525-6","article-title":"Soluble SLAMF7 promotes the growth of myeloma cells via homophilic interaction with surface SLAMF7","volume":"34","author":"Kikuchi","year":"2020","journal-title":"Leukemia"},{"issue":"2","key":"2023081515544601500_bib18","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.1365-2141.2002.03258.x","article-title":"Differential expression of CD56 and CD44 in the evolution of extramedullary myeloma","volume":"116","author":"Dahl","year":"2002","journal-title":"Br J Haematol"},{"issue":"6","key":"2023081515544601500_bib19","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1182\/blood-2011-07-368050","article-title":"P-selectin glycoprotein ligand regulates the interaction of multiple myeloma cells with the bone marrow microenvironment","volume":"119","author":"Azab","year":"2012","journal-title":"Blood"},{"issue":"4","key":"2023081515544601500_bib20","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.celrep.2015.06.059","article-title":"CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal-transition-like transcriptional activation","volume":"12","author":"Roccaro","year":"2015","journal-title":"Cell Rep"},{"issue":"1-2","key":"2023081515544601500_bib21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1083\/jcb.124.1.71","article-title":"Expression and modulation of CD44 variant isoforms in humans","volume":"124","author":"Mackay","year":"1994","journal-title":"J\u00a0Cell Biol"},{"issue":"1","key":"2023081515544601500_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1172\/JCI1604","article-title":"Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44\/HA-dependent primary adhesion","volume":"101","author":"Mohamadzadeh","year":"1998","journal-title":"J\u00a0Clin Invest"},{"issue":"3","key":"2023081515544601500_bib23","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2011.01.038","article-title":"CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth","volume":"19","author":"Ishimoto","year":"2011","journal-title":"Cancer Cell"},{"issue":"1","key":"2023081515544601500_bib24","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1158\/2159-8290.CD-18-0065","article-title":"Homophilic CD44 interactions mediate tumor cell aggregation and polyclonal metastasis in patient-derived breast cancer models","volume":"9","author":"Liu","year":"2019","journal-title":"Cancer Discov"},{"issue":"12","key":"2023081515544601500_bib25","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0145-2126(01)00075-3","article-title":"CD44 isoforms are differentially regulated in plasma cell dyscrasias and CD44v9 represents a new independent prognostic parameter in multiple myeloma","volume":"25","author":"Eisterer","year":"2001","journal-title":"Leuk Res"},{"issue":"6","key":"2023081515544601500_bib26","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/bjh.13383","article-title":"Incidence and clinical features of extramedullary multiple myeloma in patients who underwent stem cell transplantation","volume":"169","author":"Weinstock","year":"2015","journal-title":"Br J Haematol"},{"issue":"12","key":"2023081515544601500_bib27","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1182\/blood.V93.12.4144","article-title":"Serum hyaluronan in patients with multiple myeloma: correlation with survival and Ig concentration","volume":"93","author":"Dahl","year":"1999","journal-title":"Blood"},{"issue":"12","key":"2023081515544601500_bib28","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1128\/MCB.25.12.5183-5195.2005","article-title":"Combination of hTERT and bmi-1, E6, or E7 induces prolongation of the life span of bone marrow stromal cells from an elderly donor without affecting their neurogenic potential","volume":"25","author":"Mori","year":"2005","journal-title":"Mol Cell Biol"},{"issue":"2","key":"2023081515544601500_bib29","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1182\/blood-2002-04-1268","article-title":"Ex\u00a0vivo expansion of human umbilical cord hematopoietic progenitor cells using a coculture system with human telomerase catalytic subunit (hTERT)-transfected human stromal cells","volume":"101","author":"Kawano","year":"2003","journal-title":"Blood"},{"issue":"12","key":"2023081515544601500_bib30","doi-asserted-by":"crossref","first-page":"e51892","DOI":"10.1371\/journal.pone.0051892","article-title":"A\u00a0novel mouse model for multiple myeloma (MOPC315.BM) that allows noninvasive spatiotemporal detection of osteolytic disease","volume":"7","author":"Hofgaard","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"2023081515544601500_bib31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1182\/blood-2012-01-379024","article-title":"Myeloma as a model for the process of metastasis: implications for therapy","volume":"120","author":"Ghobrial","year":"2012","journal-title":"Blood"},{"issue":"1","key":"2023081515544601500_bib32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-0038-1646173","article-title":"The effects of flow on blood coagulation and thrombosis","volume":"70","author":"Slack","year":"1993","journal-title":"Thromb Haemost"},{"issue":"12","key":"2023081515544601500_bib33","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1002\/jcp.22680","article-title":"Shear flow-induced formation of tubular cell protrusions in multiple myeloma cells","volume":"226","author":"Porat","year":"2011","journal-title":"J\u00a0Cell Physiol"},{"issue":"1","key":"2023081515544601500_bib34","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1074\/jbc.273.1.338","article-title":"Identification of CD44 residues important for hyaluronan binding and delineation of the binding site","volume":"273","author":"Bajorath","year":"1998","journal-title":"J\u00a0Biol Chem"},{"issue":"5","key":"2023081515544601500_bib35","doi-asserted-by":"crossref","first-page":"6450","DOI":"10.18632\/oncotarget.24030","article-title":"Lysine-specific demethylase 1 inhibitors prevent teratoma development from human induced pluripotent stem cells","volume":"9","author":"Osada","year":"2018","journal-title":"Oncotarget"},{"issue":"1-2","key":"2023081515544601500_bib36","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.cell.2018.11.046","article-title":"Circulating tumor cell clustering shapes DNA methylation to enable metastasis seeding","volume":"176","author":"Gkountela","year":"2019","journal-title":"Cell"},{"issue":"2","key":"2023081515544601500_bib37","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41375-019-0588-4","article-title":"Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination","volume":"34","author":"Garc\u00e9s","year":"2020","journal-title":"Leukemia"},{"issue":"8","key":"2023081515544601500_bib38","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/hep4.1721","article-title":"Cluster of differentiation 44 promotes liver fibrosis and serves as a biomarker in congestive hepatopathy","volume":"5","author":"Osawa","year":"2021","journal-title":"Hepatol Commun"},{"issue":"1","key":"2023081515544601500_bib39","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/sj.leu.2402336","article-title":"CD44 variant isoforms are involved in plasma cell adhesion to bone marrow stromal cells","volume":"16","author":"Van Driel","year":"2002","journal-title":"Leukemia"},{"issue":"6","key":"2023081515544601500_bib40","doi-asserted-by":"crossref","first-page":"e581","DOI":"10.1038\/bcj.2017.56","article-title":"A\u00a0gene expression signature distinguishes innate response and resistance to proteasome inhibitors in multiple myeloma","volume":"7","author":"Mitra","year":"2017","journal-title":"Blood Cancer J"},{"issue":"12","key":"2023081515544601500_bib41","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1349-7006.2004.tb03179.x","article-title":"Mechanism and biological significance of CD44 cleavage","volume":"95","author":"Nagano","year":"2004","journal-title":"Cancer Sci"},{"issue":"12","key":"2023081515544601500_bib42","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/s41408-017-0001-3","article-title":"Jagged1-induced Notch activation contributes to the acquisition of bortezomib resistance in myeloma cells","volume":"7","author":"Muguruma","year":"2017","journal-title":"Blood Cancer J"},{"key":"2023081515544601500_bib43","first-page":"1","article-title":"Notch1-JAG1 signaling induces aggressive myeloma cell behaviors","volume":"10","author":"Ishibashi","year":"2020","journal-title":"Int. J. Myeloma"},{"issue":"14","key":"2023081515544601500_bib44","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1016\/j.yexcr.2013.06.003","article-title":"Colon cancer mesenchymal stem cells modulate the tumorigenicity of colon cancer through interleukin 6","volume":"319","author":"Lin","year":"2013","journal-title":"Exp Cell Res"},{"issue":"3","key":"2023081515544601500_bib45","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ccr.2010.08.006","article-title":"The Notch\/Hes1 pathway sustains NF-\u03baB activation through CYLD repression in T cell leukemia","volume":"18","author":"Espinosa","year":"2010","journal-title":"Cancer Cell"},{"issue":"7","key":"2023081515544601500_bib46","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1172\/JCI92981","article-title":"The NOTCH1\/CD44 axis drives pathogenesis in a T cell acute lymphoblastic leukemia model","volume":"128","author":"Garc\u00eda-Peydr\u00f3","year":"2018","journal-title":"J\u00a0Clin Invest"},{"key":"2023081515544601500_bib47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fimmu.2015.00043","article-title":"Hyaluronan synthase 1: a mysterious enzyme with unexpected functions","volume":"6","author":"Siiskonen","year":"2015","journal-title":"Front Immunol"},{"issue":"7","key":"2023081515544601500_bib48","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1182\/blood-2002-01-0030","article-title":"Characterization of hyaluronan synthase expression and hyaluronan synthesis in bone marrow mesenchymal progenitor cells: predominant expression of HAS1 mRNA and up-regulated hyaluronan synthesis in bone marrow cells derived from multiple myeloma patients","volume":"100","author":"Calabro","year":"2002","journal-title":"Blood"},{"issue":"5","key":"2023081515544601500_bib49","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1038\/s41375-021-01147-y","article-title":"Characterization of complete lncRNAs transcriptome reveals the functional and clinical impact of lncRNAs in multiple myeloma","volume":"35","author":"Carrasco-Leon","year":"2021","journal-title":"Leukemia"},{"issue":"3","key":"2023081515544601500_bib50","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1158\/0008-5472.CAN-12-2850","article-title":"The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells","volume":"73","author":"Gutschner","year":"2013","journal-title":"Cancer Res"},{"issue":"1","key":"2023081515544601500_bib51","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1186\/1471-2407-14-809","article-title":"MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression","volume":"14","author":"Cho","year":"2014","journal-title":"BMC Cancer"},{"issue":"3","key":"2023081515544601500_bib52","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/bjh.14882","article-title":"Long non-coding RNA MALAT1 is an inducible stress response gene associated with extramedullary spread and poor prognosis of multiple myeloma","volume":"179","author":"Handa","year":"2017","journal-title":"Br J Haematol"},{"issue":"4","key":"2023081515544601500_bib53","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1182\/bloodadvances.2017008847","article-title":"Hypoxia-inducible KDM3A addiction in multiple myeloma","volume":"2","author":"Ikeda","year":"2018","journal-title":"Blood Adv"},{"issue":"8","key":"2023081515544601500_bib54","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1182\/blood-2006-09-044974","article-title":"Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib","volume":"109","author":"Mulligan","year":"2007","journal-title":"Blood"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/4\/508\/2071492\/blooda_adv-2022-007291-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/4\/508\/2071492\/blooda_adv-2022-007291-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T12:03:43Z","timestamp":1692101023000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/4\/508\/486121\/EMD-originates-from-hyaluronan-induced-homophilic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,16]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,2,28]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2022007291","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,16]]}}}